“Company Business Analysis and Segment Overview” (CBASO) is designed to provide a concise executive summary of a leading company in a particular industry and that company’s applicable sector focus.

This CBASO examines the technology and products for the molecular biology of Applied Biosystems, Inc. (ABI), which consists of two business units: Applera Corporation and Celera Genomics Group.

The CBASO also covers: 1) polymerase chain reaction (PCR) PCR technology, 2) ABI's expanded licensing program and 3) company acquisitions, partnerships and collaborations with different companies.

In the process, this CBASO details the proteomics market, recent product introductions in the molecular biology market, and a general overview on gene expression technology.